Child Health Division, Menzies School of Health Research, Darwin, Australia.
BMC Infect Dis. 2010 Oct 23;10:304. doi: 10.1186/1471-2334-10-304.
To determine the prevalence of carriage of respiratory bacterial pathogens, and the risk factors for and serotype distribution of pneumococcal carriage in an Australian Aboriginal population.
Surveys of nasopharyngeal carriage of Streptococcus pneumoniae, non-typeable Haemophilus influenzae, and Moraxella catarrhalis were conducted among adults (≥16 years) and children (2 to 15 years) in four rural communities in 2002 and 2004. Infant seven-valent pneumococcal conjugate vaccine (7PCV) with booster 23-valent pneumococcal polysaccharide vaccine was introduced in 2001. Standard microbiological methods were used.
At the time of the 2002 survey, 94% of eligible children had received catch-up pneumococcal vaccination. 324 adults (538 examinations) and 218 children (350 examinations) were enrolled. Pneumococcal carriage prevalence was 26% (95% CI, 22-30) among adults and 67% (95% CI, 62-72) among children. Carriage of non-typeable H. influenzae among adults and children was 23% (95% CI, 19-27) and 57% (95% CI, 52-63) respectively and for M. catarrhalis, 17% (95% CI, 14-21) and 74% (95% CI, 69-78) respectively. Adult pneumococcal carriage was associated with increasing age (p = 0.0005 test of trend), concurrent carriage of non-typeable H. influenzae (Odds ratio [OR] 6.74; 95% CI, 4.06-11.2) or M. catarrhalis (OR 3.27; 95% CI, 1.97-5.45), male sex (OR 2.21; 95% CI, 1.31-3.73), rhinorrhoea (OR 1.66; 95% CI, 1.05-2.64), and frequent exposure to outside fires (OR 6.89; 95% CI, 1.87-25.4). Among children, pneumococcal carriage was associated with decreasing age (p < 0.0001 test of trend), and carriage of non-typeable H. influenzae (OR 9.34; 95% CI, 4.71-18.5) or M. catarrhalis (OR 2.67; 95% CI, 1.34-5.33). Excluding an outbreak of serotype 1 in children, the percentages of serotypes included in 7, 10, and 13PCV were 23%, 23%, and 29% (adults) and 22%, 24%, and 40% (2-15 years). Dominance of serotype 16F, and persistent 19F and 6B carriage three years after initiation of 7PCV is noteworthy.
Population-based carriage of S. pneumoniae, non-typeable H. influenzae, and M. catarrhalis was high in this Australian Aboriginal population. Reducing smoke exposure may reduce pneumococcal carriage. The indirect effects of 10 or 13PCV, above those of 7PCV, among adults in this population may be limited.
为了确定呼吸道细菌病原体的携带率,以及在澳大利亚原住民人群中肺炎球菌携带的危险因素和血清型分布。
2002 年和 2004 年,在四个农村社区对成年人(≥16 岁)和儿童(2 至 15 岁)进行了鼻咽部肺炎链球菌、非定型流感嗜血杆菌和卡他莫拉菌的调查。2001 年引入了婴儿 7 价肺炎球菌结合疫苗(7PCV)和加强型 23 价肺炎球菌多糖疫苗。采用标准微生物学方法。
在 2002 年调查时,94%符合条件的儿童已接受了肺炎球菌补种疫苗接种。共纳入 324 名成年人(538 次检查)和 218 名儿童(350 次检查)。成年人的肺炎球菌携带率为 26%(95%CI,22-30),儿童为 67%(95%CI,62-72)。成年人和儿童的非定型流感嗜血杆菌携带率分别为 23%(95%CI,19-27)和 57%(95%CI,52-63),卡他莫拉菌的携带率分别为 17%(95%CI,14-21)和 74%(95%CI,69-78)。成人肺炎球菌携带与年龄增长有关(p=0.0005 趋势检验),同时携带非定型流感嗜血杆菌(比值比[OR]6.74;95%CI,4.06-11.2)或卡他莫拉菌(OR 3.27;95%CI,1.97-5.45)、男性(OR 2.21;95%CI,1.31-3.73)、流鼻涕(OR 1.66;95%CI,1.05-2.64)和经常接触户外火源(OR 6.89;95%CI,1.87-25.4)。在儿童中,肺炎球菌携带与年龄减小有关(p<0.0001 趋势检验),与非定型流感嗜血杆菌(OR 9.34;95%CI,4.71-18.5)或卡他莫拉菌(OR 2.67;95%CI,1.34-5.33)有关。排除儿童中 1 型血清型爆发后,7、10 和 13PCV 纳入的血清型百分比分别为 23%、23%和 29%(成年人)和 22%、24%和 40%(2-15 岁)。16F 血清型的优势以及 7PCV 接种后三年 19F 和 6B 的持续携带值得关注。
在澳大利亚原住民人群中,人群中存在高比例的肺炎链球菌、非定型流感嗜血杆菌和卡他莫拉菌的携带。减少烟雾暴露可能会降低肺炎球菌的携带率。在该人群中,10 价或 13 价 PCV 的间接作用(超过 7 价 PCV)可能有限。